Business Description
Conmed Corp
NAICS : 334510
SIC : 3845
ISIN : US2074101013
Share Class Description:
CNMD: Ordinary SharesTotal Employee Number:
3,900Description
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.85 | |||||
Debt-to-EBITDA | 4.62 | |||||
Interest Coverage | 3.75 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 1.91 | |||||
Beneish M-Score | -2.64 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.2 | |||||
3-Year EBITDA Growth Rate | 83.4 | |||||
3-Year EPS without NRI Growth Rate | 20.1 | |||||
3-Year FCF Growth Rate | 132.6 | |||||
3-Year Book Growth Rate | 10.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 6.05 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.46 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 82.08 | |||||
9-Day RSI | 74.82 | |||||
14-Day RSI | 68.99 | |||||
3-1 Month Momentum % | -13.39 | |||||
6-1 Month Momentum % | -19.72 | |||||
12-1 Month Momentum % | -30 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.29 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.12 | |||||
Days Inventory | 214.24 | |||||
Days Sales Outstanding | 61.61 | |||||
Days Payable | 59.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.9 | |||||
Dividend Payout Ratio | 0.09 | |||||
3-Year Dividend Growth Rate | -9.1 | |||||
Forward Dividend Yield % | 1.79 | |||||
5-Year Yield-on-Cost % | 0.73 | |||||
3-Year Average Share Buyback Ratio | -0.5 | |||||
Shareholder Yield % | 9.09 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.17 | |||||
Operating Margin % | 8.18 | |||||
Net Margin % | 4 | |||||
EBITDA Margin % | 13.61 | |||||
FCF Margin % | 9.03 | |||||
OCF Margin % | 10.41 | |||||
ROE % | 5.44 | |||||
ROA % | 2.37 | |||||
ROIC % | 3.45 | |||||
3-Year ROIIC % | 54.09 | |||||
ROC (Joel Greenblatt) % | 25.47 | |||||
ROCE % | 5.53 | |||||
Years of Profitability over Past 10-Year | 9 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 25.43 | |||||
Forward PE Ratio | 10.36 | |||||
PE Ratio without NRI | 9.89 | |||||
Shiller PE Ratio | 30.62 | |||||
Price-to-Owner-Earnings | 15.68 | |||||
PEG Ratio | 0.65 | |||||
PS Ratio | 1.02 | |||||
PB Ratio | 1.33 | |||||
Price-to-Free-Cash-Flow | 11.3 | |||||
Price-to-Operating-Cash-Flow | 9.78 | |||||
EV-to-EBIT | 19.53 | |||||
EV-to-Forward-EBIT | 24.24 | |||||
EV-to-EBITDA | 11.69 | |||||
EV-to-Forward-EBITDA | 16.5 | |||||
EV-to-Revenue | 1.59 | |||||
EV-to-Forward-Revenue | 3.66 | |||||
EV-to-FCF | 17.63 | |||||
Price-to-GF-Value | 0.61 | |||||
Price-to-Projected-FCF | 0.75 | |||||
Price-to-DCF (Earnings Based) | 0.61 | |||||
Price-to-DCF (FCF Based) | 0.63 | |||||
Price-to-Median-PS-Value | 0.42 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.46 | |||||
Earnings Yield (Greenblatt) % | 5.12 | |||||
FCF Yield % | 9.13 | |||||
Forward Rate of Return (Yacktman) % | 27.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:CNMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Conmed Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,370.515 | ||
| EPS (TTM) ($) | 1.77 | ||
| Beta | 1.0967 | ||
| 3-Year Sharpe Ratio | -1.31 | ||
| 3-Year Sortino Ratio | -1.45 | ||
| Volatility % | 36.5 | ||
| 14-Day RSI | 68.99 | ||
| 14-Day ATR ($) | 2.159647 | ||
| 20-Day SMA ($) | 35.515 | ||
| 12-1 Month Momentum % | -30 | ||
| 52-Week Range ($) | 31.44 - 56.635 | ||
| Shares Outstanding (Mil) | 30.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Conmed Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Conmed Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 16:30 | In 113 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 112 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-29 16:30 | In 14 days | ||
| Second quarter earnings results for 2026 | 2026-07-29 | In 13 days | ||
| First quarter earnings conference call for 2026 | 2026-04-29 16:30 | 36.79 (-2.67%) | ||
| First quarter earnings results for 2026 | 2026-04-29 | 36.79 (-2.67%) | ||
| Annual report for 2025 | 2026-02-17 | 41.80 (-0.24%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-01-28 16:30 | 39.58 (-2.32%) | ||
| Fourth quarter earnings results for 2025 | 2026-01-28 | 39.58 (-2.32%) | ||
| 44th Annual J.P. Morgan Healthcare Conference | 2026-01-12 18:00 | 42.91 (-0.76%) |
Show
Entries
Conmed Corp Frequently Asked Questions
What is Conmed Corp(CNMD)'s stock price today?
The current price of CNMD is $45.01. The 52 week high of CNMD is $56.64 and 52 week low is $31.44.
When is next earnings date of Conmed Corp(CNMD)?
The next earnings date of Conmed Corp(CNMD) is 2026-07-29.
Does Conmed Corp(CNMD) pay dividends? If so, how much?
The Dividend Yield %  of Conmed Corp(CNMD) is 0.9% (As of Today), Highest Dividend Payout Ratio of Conmed Corp(CNMD) was 0.44. The lowest was 0.09. And the median was 0.3. The  Forward Dividend Yield % of Conmed Corp(CNMD) is 1.79%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on NYSE:CNMD
No articles.
Press Release
Articles on Conmed Corp
Headlines
See More- 1
Jul 10, 2026
Conmed jumps after report of takeover interest
Seeking Alpha • 3:46pm
Jun 18, 2026
At a glance: stocks gapping up premarket
Seeking Alpha • 6:29am
Jun 17, 2026
CONMED names John Gallagher as chief financial officer
Seeking Alpha • 3:53pm
- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers